Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020
Soraya Matczak, Corinne Lévy, Camille Fortas, et al.
Eurosurveillance (2022) Vol. 27, Iss. 25
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024
Carla Rodrigues, Valérie Bouchez, Anaïs Soares, et al.
Eurosurveillance (2024) Vol. 29, Iss. 31
Open Access | Times Cited: 15
Global, regional and national trends in incidence and mortality of pertussis from 1990 to 2021 and the comparison before and during COVID-19: a modelling analysis
Shimo Zhang, Sijia Wang, Jue Liu
Journal of Infection and Public Health (2025) Vol. 18, Iss. 4, pp. 102696-102696
Open Access | Times Cited: 1
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
Elise Tessier, Helen Campbell, Sonia Ribeiro, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 43
All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) compared with the pre-pandemic period (2015–19) in South Africa: an observational study
Alane Izu, Marta C. Nunes, Fatima Solomon, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 9, pp. 1031-1041
Open Access | Times Cited: 38
Pertussis vaccines, epidemiology and evolution
Matthieu Domenech de Cellès, Pejman Rohani
Nature Reviews Microbiology (2024) Vol. 22, Iss. 11, pp. 722-735
Closed Access | Times Cited: 13
Virological characterization of Parvovirus B19 isolated during the atypical 2023-2024 outbreak in France
Nicolas Veyrenche, Jacques Fourgeaud, Marianne Burgard, et al.
Journal of Infection (2025) Vol. 90, Iss. 2, pp. 106409-106409
Open Access
Impact of modifications to pertussis case definition on epidemiological characteristics of pertussis in mainland China
Jian Shen, Ying Yuan, L. T. T. Le
Pulmonology (2025) Vol. 31, Iss. 1
Open Access
Clinical characteristics of cases during the 2024 pertussis epidemic in France, January 2024 to December 2024
Thomas Monchausse, Titouan Launay, Louise Rossignol, et al.
Vaccine (2025) Vol. 51, pp. 126862-126862
Open Access
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?
Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Antibody Response to Pertussis Vaccine Among Children and Adolescents in Croatia: A Cross-Sectional Prevalence Study
Vedran Stevanović, Oktavija Đaković Rode, Goran Tešović
Vaccines (2025) Vol. 13, Iss. 3, pp. 288-288
Open Access
European Pediatric Societies Call for an Implementation of Regular Vaccination Programs to Contrast the Immunity Debt Associated to Coronavirus Disease-2019 Pandemic in Children
Robert Cohen, Massimo Pettoello‐Mantovani, Eli Somekh, et al.
The Journal of Pediatrics (2021) Vol. 242, pp. 260-261.e3
Open Access | Times Cited: 37
Detection of Bordetella spp. in children with pertussis-like illness from 2018 to 2024 in China
Yahong Hu, Wei Shi, Qinghong Meng, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106222-106222
Open Access | Times Cited: 4
Global patterns of syphilis, gonococcal infection, typhoid fever, paratyphoid fever, diphtheria, pertussis, tetanus, and leprosy from 1990 to 2021: findings from the Global Burden of Disease Study 2021
Weiye Chen, Yi‐Ming Chen, Zile Cheng, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicenter study in France, 2008-2019
Pauline Leroux, Soraya Matczak, Valérie Bouchez, et al.
Clinical Microbiology and Infection (2024) Vol. 31, Iss. 2, pp. 233-239
Closed Access | Times Cited: 3
Post-COVID-19 pandemic outbreak of severe Parvovirus B19 primary infections in Paris, France: 10-year interrupted time-series analysis (2012–2023)
Jacques Fourgeaud, Slimane Allali, Julie Toubiana, et al.
Journal of Clinical Virology (2023) Vol. 167, pp. 105576-105576
Closed Access | Times Cited: 7
Transient reemergence of Bordetella parapertussis in France in 2022
Valérie Bouchez, Julie Toubiana, Sophie Guillot, et al.
Journal of Medical Microbiology (2024) Vol. 73, Iss. 7
Closed Access | Times Cited: 2
Viral and Bacterial Respiratory Pathogens during the COVID-19 Pandemic in Israel
Yonatan Oster, Wiessam Abu Ahmad, Ayelet Michael-Gayego, et al.
Microorganisms (2023) Vol. 11, Iss. 1, pp. 166-166
Open Access | Times Cited: 5
Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases
Amy B Rubis, Matt Cole, M. Lucia Tondella, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. 6, pp. 1727-1731
Open Access | Times Cited: 1
Pertussis vaccination in adults in France: Overview and suggestions for improvement
Élodie Blanchard, D Chavade, B. de Wazières, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 6, pp. 104961-104961
Open Access | Times Cited: 1
The impact of COVID-19 non-pharmaceutical interventions on Bordetella pertussis, human respiratory syncytial virus, influenza virus and seasonal coronavirus antibody levels; A systematic review
Channah M Gaasbeek, Maxime Visser, Rory D. de Vries, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 1
Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020
Marion Debin, Titouan Launay, Louise Rossignol, et al.
Eurosurveillance (2022) Vol. 27, Iss. 17
Open Access | Times Cited: 8
Pediatric ambulatory pertussis epidemiology in France, recent updates
Corinne Lévy, Robert Cohen, Stéphane Béchet, et al.
Infectious Diseases Now (2023) Vol. 53, Iss. 6, pp. 104727-104727
Open Access | Times Cited: 3
Evaluation of the economic efficacy of vaccination against pertussis based on real-world data
S. V. Svetlichnaya, L. A. Elagina, L. D. Popovich
Real-World Data & Evidence (2023) Vol. 3, Iss. 1, pp. 09-19
Open Access | Times Cited: 2
The impact of mitigation measures against COVID-19 on the incidence of pertussis and its evaluation using the ARIMA model
Sonya O. Vysochanskaya, A. A. Basov, Yury V. Zhernov, et al.
Informatics in Medicine Unlocked (2023) Vol. 42, pp. 101389-101389
Open Access | Times Cited: 2
Pilot Study on Evaluating the Impact of Tetanus, Diphtheria, and Pertussis (Tdap), Influenza, and COVID-19 Vaccinations on Antibody Responses in Pregnant Women
Wei‐Chun Chen, Shu-Yu Hu, Chao‐Min Cheng, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 312-312
Open Access
Page 1 - Next Page

Scroll to top